 HERZLIYA, Israel, Jan. 07, 2021 GLOBE NEWSWIRE -- PainReform Ltd. Nasdaq: PRFX PainReform or the Company, a clinical stage specialty pharmaceutical company focused on the reformulation of established therapeutics, today announced that it will be presenting at the H.C. Wainwright BioConnect 2021 Conference, being held virtually between January 11-14, 2021. 